查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
BNP和NT-proBNP全球市場規模,份額,行業趨勢分析報告,按測試地點,應用(心肌梗塞,急性冠狀動脈綜合徵(ACS),充血性心力衰竭(CHF)),地區展望和預測,2022-2028 年
市場調查報告書
商品編碼
1261169

BNP和NT-proBNP全球市場規模,份額,行業趨勢分析報告,按測試地點,應用(心肌梗塞,急性冠狀動脈綜合徵(ACS),充血性心力衰竭(CHF)),地區展望和預測,2022-2028 年

Global Bnp and Ntprobnp Market Size, Share & Industry Trends Analysis Report By Location of Testing, By Application (Myocardial Infarction, Acute Coronary Syndrome (ACS), Congestive Heart Failure (CHF)), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 170 Pages | 訂單完成後即時交付

價格

BNP 和 NT-proBNP 市場規模預計將在 2028 年達到 22 億美元，預測期內市場複合年增長率為 11.4%。

但是，高水平可能表明心臟沒有為身體提供足夠的血液。 在這種情況下會發生心力衰竭，有時稱為充血性心力衰竭。 利鈉□測定法測量血液中 NT-proBNP 或 BNP 的濃度。 兩者都有不同的參數，所有這些都可用於診斷心力衰竭。 選項用戶將依賴提供商提議的實驗室擁有的工具。

BNP 和 NT-proBNP 之間的主要生物學區別是 BNP 作為一種激素並且具有生物活性。 相比之下，NT-proBNP 不僅被動排出體外，而且沒有生物活性。 因此，NT-proBNP 的半衰期往往比 BNP 更長，後者的半衰期明顯更短。 因此，NT-proBNP 在血流中含量豐富，並且在一定程度上以較高水平循環，這表明它對識別早期心力衰竭具有很高的敏感性。

COVID-19 影響分析

COVID-19 大流行封鎖期對 BNP 和 NT-proBNP 市場產生了負面影響。 這是由於政府嚴格控制和限制，心髒病診斷檢查的數量減少了。 此外，COVID 期間知識水平低和診斷測試價格高進一步阻礙了市場增長。 然而，COVID-19 也可引起靜脈和動脈血栓形成、心律失常和心肌梗塞。 因此，優化心髒病的檢測和治療至關重要，最終會增加床旁 BNP 和 NT-proBNP 檢測的使用。

市場增長因素

世界範圍內 CAD、AMI 和 CHF 的患病率正在上升

根據全球健康數據交換數據庫，目前全球估計有 6434 萬充血性心力衰竭 (CHF) 病例。 這相當於 3461.7 億美元用於醫療保健和 991 萬 YLD（因殘疾而損失的年數）。 HF 受年齡的影響很大。 此外，心血管問題會顯著損害患者的功能能力並增加死亡風險。 因此，正確診斷和治療這種疾病對於避免重複住院、優化患者預後和提高生活質量至關重要。 因此，心血管疾病在人群中日益流行將為主要市場進入者提供產品投資和商業化機會，從而加速 BNP 和 NT-proBNP 市場的增長。

擴大 BNP 和 NT-proBNP 檢測在慢性腎病中的應用

心臟會受到這些變化的影響，隨著時間的推移會發展為心肌病和充血性心力衰竭。 這種參與的標誌物包括利鈉□，例如 BNP 和 NT-proBNP。 CKD 患者的利鈉□水平升高，尤其是透析患者。 BNP 水平隨時間的變化已被確定為更準確的 CKD 風險指標。 需要強調的是，腎功能和 NT-pro-BNP 水平在腎功能衰竭中呈高度負相關。 因此，越來越多地使用 BNP 和 NT proBNP 儀表來準確診斷腎功能和治療 CKD 正在推動市場的擴張。

市場約束

BNP 和 NT-proBNP 測定的不相容性

儘管人們普遍認為這兩種測試在臨床上基本等效，但在既定的切點上評估了 HF 排除與 BNP 和 NT-proBNP 排除之間的診斷一致性。沒有已發表的研究。 在測量患者樣本中的 BNP 和 NT-proBNP 時，已經確定了幾個因素，例如抗體與其前體 proBNP 的反應性差異、半衰期、腎臟清除率、蛋白質糖基化以及 HF 患者生化多樣性的變化。有一些很好的- 已知問題。 因此，很明顯 BNP 和 NT-proBNP 不能互換使用。 這增加了這些測試分析的成本並減緩了市場增長。

應用展望

根據應用，BNP 和 NT-proBNP 市場分為心肌梗塞、充血性心力衰竭 (CHF)、急性冠脈綜合徵 (ACS) 等。 在 2021 年的 BNP 和 NT-proBNP 市場中，充血性心力衰竭部分正在獲得可觀的增長率。 充血性心力衰竭 (CHF) 是一種輕微的慢性疾病，會損害心肌的收縮能力。 這些指標已被證明可以降低急診科的成本，並可用於識別心力衰竭，尤其是舒張功能障礙。 BNP 測試的高陰性預測準確性對於排除心力衰竭特別有用。

考察地點前景

根據檢測地點，BNP 和 NT-proBNP 市場分為即時檢測和實驗室檢測。 2021 年的 BNP 和 NT-proBNP 市場將由即時檢測領域主導。 原因包括更好的資源利用、改善患者的便利性、增加對心臟生物標誌物檢測的需求以及改善臨床決策。 這也歸功於改進了心力衰竭的診斷和治療。 許多即時檢測儀器包括試劑盒、化驗、分析儀和測試專用設備。

區域展望

基於區域，對北美、歐洲、亞太地區和 LAMEA 的 BNP 和 NT-proBNP 市場進行了分析。 2021 年，北美地區在 BNP 和 NT-proBNP 市場的收入份額最大。 這可能是由於先進的醫療保健系統以及 BNP 和 NT-proBNP 作為疾病診斷和預後工具的廣泛使用。 此外，由於老年人口的增加，對診斷急性心肌梗死等疾病的生物標誌物檢測的需求增加，對檢測產品的需求也越來越大。 推動該市場擴張的另一個因素是該地區重要公司的集中。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場範圍
  • 細分
    • BNP 和 NT-proBNP 的全球市場：按測試地點分類
    • BNP 和 NT-proBNP 全球市場：按應用分類
    • BNP 和 NT-proBNP 全球市場：按地區
  • 調查方法

第 2 章市場概述

  • 介紹
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動力
    • 市場製約因素

第 3 章全球 BNP 和 NT-proBNP 市場：按試驗點分類

  • 全球即時檢驗市場：按地區
  • 全球實驗室測試市場：按地區

第 4 章 BNP 和 NT-proBNP 的全球市場：按應用分類

  • 全球心臟梗死市場：按地區
  • 全球急性冠狀動脈綜合徵 (ACS) 市場：按地區
  • 全球充血性心力衰竭 (CHF) 市場：按地區
  • 按地區劃分的其他全球市場

第 5 章 BNP 和 NT-proBNP 的全球市場：按地區分類

  • 北美
    • 按國家/地區劃分的北美 BNP 和 NT-proBNP 市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 按國家/地區劃分的歐洲 BNP 和 NT-proBNP 市場
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太地區 BNP 和 NT-proBNP 市場：按國家/地區細分
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • 按國家/地區劃分的 LAMEA BNP 和 NT-proBNP 市場
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • LAMEA 的其餘部分

第六章公司簡介

  • Abbott Laboratories
  • Siemens AG
  • Danaher Corporation
  • Gentian Diagnostics ASA
  • PerkinElmer, Inc
  • BioMerieux SA
  • Quidel Corporation
  • Bio-Rad laboratories, Inc
  • F Hoffmann-La Roche Ltd.（Roche Holding Ltd.）
  • Scripps Laboratories

The Global Bnp And Ntprobnp Market size is expected to reach $2.2 billion by 2028, rising at a market growth of 11.4% CAGR during the forecast period.

BNP (B-type natriuretic peptide) & NT-proBNP (N-terminal pro B-type natriuretic peptide) are two extensively used biomarkers that are used to diagnose heart failure and lower ejection fraction, evaluate the effectiveness of therapy, and predict outcomes. As cardiomyocytes stretch, they release proBNP, which breaks down into two circulating fragments. The first fragment is the 32-amino acid C-terminal BNP, and the second fragment is inactive 76-amino acid NT-proBNP.

Both pieces are frequently utilized to aid in detecting heart failure, make predictions about results, and monitor the impact of treatment. The heart produces peptides known as natriuretic peptides. N-terminal pro-B-type natriuretic peptide and Brain natriuretic peptide (BNP) are the two primary forms of these chemicals. BNP & NT-proBNP are typically only detected in trace amounts in the blood.

However, high levels may indicate that the heart isn't supplying the body with enough blood as it requires. Heart failure, sometimes called congestive heart failure, occurs when this happens. Natriuretic peptide assays gauge the blood's levels of NT-proBNP or BNP. Although they employ various parameters, they are both helpful in diagnosing heart failure. The option users will rely on the tools the suggested laboratory of the provider has.

The main biological distinction between BNP & NT-proBNP is that BNP acts as a hormone and is biologically active. In contrast, NT-proBNP is passively excreted from the body as well as is not biologically active. Thus, NT-proBNP tends to have a longer half-life than BNP, which has a significantly shorter half-life. As a result, NT-proBNP circulates in the bloodstream at higher quantities, which suggests that it is more likely to be sensitive for identifying earlier stages of heart failure since it does so at somewhat elevated levels.

COVID-19 Impact Analysis

The COVID-19 pandemic lockdown period had a negative effect on the BNP and NTproBNP market. This is due to stringent governmental controls and limits that resulted in fewer cardiac disease diagnostic tests being performed. In addition, the low level of knowledge and the high price of diagnostic tests during the COVID period further hindered market growth. COVID-19, however, was also capable of causing venous and arterial thrombosis, arrhythmia, and cardiac damage. Thus, optimizing cardiac illness detection and therapy was crucial, which eventually led to a rise in the usage of point-of-care BNP & NT-proBNP testing.

Market Growth Factors

Rising prevalence of CAD, AMI, and CHF around the world

The Global Health Data Exchange database estimates that there is currently 64.34 million congestive heart failure (CHF) cases worldwide. This amounts to USD 346.17 billion spent on healthcare and 9.91 million YLDs (years lost due to disability). HF is significantly influenced by age. Moreover, cardiovascular issues can significantly reduce a patient's functional capacity and raise their mortality risk. Therefore, to avoid repeated hospital stays, optimize patient outcomes, and boost the quality of life, it is crucial to correctly diagnose and treat the disease. As a result, the population's increased prevalence of cardiovascular illness presents an opportunity for leading market participants to invest in and commercialize the products and, in turn, accelerate the growth of the bnp and ntprobnp market.

Growing use of bnp and Ntprobnp assays in chronic kidney disease

The heart is affected by these changes and develops cardiomyopathy and congestive heart failure over time. Markers for this involvement include natriuretic peptides like BNP and NT-proBNP. Natriuretic peptide levels are higher in people with CKD, especially those receiving dialysis. It has been observed that a more accurate risk indicator for CKD is the variations in BNP levels over time. It is important to highlight that renal function and NT-pro-BNP levels are highly inversely correlated in renal failure. Therefore, the increasing use of bnp and ntprobnp assays to diagnose renal function accurately to treat CKD has resulted in market expansion.

Market Restraining Factors

Non-interchangeable nature of bnp and ntprobnp assays

No published investigation had evaluated the diagnostic concordance of BNP & NT-proBNP for ruling out and ruling in HF at the established cut-points, despite the broad recognition that both tests are fundamentally clinically comparable. Measuring BNP or NT-proBNP in patient samples has several well-known problems, such as variable antibody reactivity with the precursor proBNP and changes in half-lives, renal clearance, protein glycosylation, and biochemical variety in HF patients. Hence, it is obvious that BNP and NT-proBNP cannot be used interchangeably. This increases the expense of these test assays and presents factors that will slow down the market's growth.

Application Outlook

Based on application, the Bnp and Ntprobnp market is categorized into myocardial infarction, congestive heart failure (CHF), acute coronary syndrome (ACS), and others. The congestive heart failure segment procured a considerable growth rate in the Bnp and Ntprobnp market in 2021. Congestive heart failure, or CHF, is a gradual, chronic illness that impairs the ability of the heart muscle to contract. These metrics have been demonstrated to reduce costs in the emergency room setting and can be used to identify heart failure, particularly diastolic dysfunction. BNP testing' high negative predictive accuracy is especially useful for excluding heart failure.

Location of Testing Outlook

On the basis of location of testing, the Bnp and Ntprobnp market is divided into point of care testing and laboratory testing. The point of care testing segment acquired the largest revenue share in the Bnp and Ntprobnp market in 2021. Better resource utilization, increased patient convenience, growth in demand for cardiology biomarker testing, and improved clinical decision-making are all credited with this. It also results from improved heart failure diagnosis and treatment. Most point-of-care testing equipment includes kits, assays, analyzers, and devices focused on testing.

Regional Outlook

Based on region, the Bnp and Ntprobnp market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed the maximum revenue share in the Bnp and Ntprobnp market in 2021. This can be ascribed to the advanced healthcare system and the widespread use of BNP and NTproBNP as diagnostic and prognostic disease tools. In addition, the need for testing products is driven by the growing elderly population's need for biomarker testing to diagnose diseases like acute myocardial infarction. Another factor boosting the expansion of this market is the concentration of important companies in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Siemens AG, Danaher Corporation, Gentian Diagnostics ASA, PerkinElmer, Inc., BioMerieux S.A., Quidel Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.), and Scripps Laboratories.

Scope of the Study

Market Segments covered in the Report:

By Location of Testing

  • Point of Care Testing
  • Laboratory Testing

By Application

  • Myocardial Infarction
  • Acute Coronary Syndrome (ACS)
  • Congestive Heart Failure (CHF)
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Siemens AG
  • Danaher Corporation
  • Gentian Diagnostics ASA
  • PerkinElmer, Inc.
  • BioMerieux S.A.
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
  • Scripps Laboratories

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Bnp And Ntprobnp Market, by Location of Testing
    • 1.4.2 Global Bnp And Ntprobnp Market, by Application
    • 1.4.3 Global Bnp And Ntprobnp Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Bnp And Ntprobnp Market by Location of Testing

  • 3.1 Global Point of Care Testing Market by Region
  • 3.2 Global Laboratory Testing Market by Region

Chapter 4. Global Bnp And Ntprobnp Market by Application

  • 4.1 Global Myocardial Infarction Market by Region
  • 4.2 Global Acute Coronary Syndrome (ACS) Market by Region
  • 4.3 Global Congestive Heart Failure (CHF) Market by Region
  • 4.4 Global Others Market by Region

Chapter 5. Global Bnp And Ntprobnp Market by Region

  • 5.1 North America Bnp And Ntprobnp Market
    • 5.1.1 North America Bnp And Ntprobnp Market by Location of Testing
      • 5.1.1.1 North America Point of Care Testing Market by Country
      • 5.1.1.2 North America Laboratory Testing Market by Country
    • 5.1.2 North America Bnp And Ntprobnp Market by Application
      • 5.1.2.1 North America Myocardial Infarction Market by Country
      • 5.1.2.2 North America Acute Coronary Syndrome (ACS) Market by Country
      • 5.1.2.3 North America Congestive Heart Failure (CHF) Market by Country
      • 5.1.2.4 North America Others Market by Country
    • 5.1.3 North America Bnp And Ntprobnp Market by Country
      • 5.1.3.1 US Bnp And Ntprobnp Market
        • 5.1.3.1.1 US Bnp And Ntprobnp Market by Location of Testing
        • 5.1.3.1.2 US Bnp And Ntprobnp Market by Application
      • 5.1.3.2 Canada Bnp And Ntprobnp Market
        • 5.1.3.2.1 Canada Bnp And Ntprobnp Market by Location of Testing
        • 5.1.3.2.2 Canada Bnp And Ntprobnp Market by Application
      • 5.1.3.3 Mexico Bnp And Ntprobnp Market
        • 5.1.3.3.1 Mexico Bnp And Ntprobnp Market by Location of Testing
        • 5.1.3.3.2 Mexico Bnp And Ntprobnp Market by Application
      • 5.1.3.4 Rest of North America Bnp And Ntprobnp Market
        • 5.1.3.4.1 Rest of North America Bnp And Ntprobnp Market by Location of Testing
        • 5.1.3.4.2 Rest of North America Bnp And Ntprobnp Market by Application
  • 5.2 Europe Bnp And Ntprobnp Market
    • 5.2.1 Europe Bnp And Ntprobnp Market by Location of Testing
      • 5.2.1.1 Europe Point of Care Testing Market by Country
      • 5.2.1.2 Europe Laboratory Testing Market by Country
    • 5.2.2 Europe Bnp And Ntprobnp Market by Application
      • 5.2.2.1 Europe Myocardial Infarction Market by Country
      • 5.2.2.2 Europe Acute Coronary Syndrome (ACS) Market by Country
      • 5.2.2.3 Europe Congestive Heart Failure (CHF) Market by Country
      • 5.2.2.4 Europe Others Market by Country
    • 5.2.3 Europe Bnp And Ntprobnp Market by Country
      • 5.2.3.1 Germany Bnp And Ntprobnp Market
        • 5.2.3.1.1 Germany Bnp And Ntprobnp Market by Location of Testing
        • 5.2.3.1.2 Germany Bnp And Ntprobnp Market by Application
      • 5.2.3.2 UK Bnp And Ntprobnp Market
        • 5.2.3.2.1 UK Bnp And Ntprobnp Market by Location of Testing
        • 5.2.3.2.2 UK Bnp And Ntprobnp Market by Application
      • 5.2.3.3 France Bnp And Ntprobnp Market
        • 5.2.3.3.1 France Bnp And Ntprobnp Market by Location of Testing
        • 5.2.3.3.2 France Bnp And Ntprobnp Market by Application
      • 5.2.3.4 Russia Bnp And Ntprobnp Market
        • 5.2.3.4.1 Russia Bnp And Ntprobnp Market by Location of Testing
        • 5.2.3.4.2 Russia Bnp And Ntprobnp Market by Application
      • 5.2.3.5 Spain Bnp And Ntprobnp Market
        • 5.2.3.5.1 Spain Bnp And Ntprobnp Market by Location of Testing
        • 5.2.3.5.2 Spain Bnp And Ntprobnp Market by Application
      • 5.2.3.6 Italy Bnp And Ntprobnp Market
        • 5.2.3.6.1 Italy Bnp And Ntprobnp Market by Location of Testing
        • 5.2.3.6.2 Italy Bnp And Ntprobnp Market by Application
      • 5.2.3.7 Rest of Europe Bnp And Ntprobnp Market
        • 5.2.3.7.1 Rest of Europe Bnp And Ntprobnp Market by Location of Testing
        • 5.2.3.7.2 Rest of Europe Bnp And Ntprobnp Market by Application
  • 5.3 Asia Pacific Bnp And Ntprobnp Market
    • 5.3.1 Asia Pacific Bnp And Ntprobnp Market by Location of Testing
      • 5.3.1.1 Asia Pacific Point of Care Testing Market by Country
      • 5.3.1.2 Asia Pacific Laboratory Testing Market by Country
    • 5.3.2 Asia Pacific Bnp And Ntprobnp Market by Application
      • 5.3.2.1 Asia Pacific Myocardial Infarction Market by Country
      • 5.3.2.2 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country
      • 5.3.2.3 Asia Pacific Congestive Heart Failure (CHF) Market by Country
      • 5.3.2.4 Asia Pacific Others Market by Country
    • 5.3.3 Asia Pacific Bnp And Ntprobnp Market by Country
      • 5.3.3.1 China Bnp And Ntprobnp Market
        • 5.3.3.1.1 China Bnp And Ntprobnp Market by Location of Testing
        • 5.3.3.1.2 China Bnp And Ntprobnp Market by Application
      • 5.3.3.2 Japan Bnp And Ntprobnp Market
        • 5.3.3.2.1 Japan Bnp And Ntprobnp Market by Location of Testing
        • 5.3.3.2.2 Japan Bnp And Ntprobnp Market by Application
      • 5.3.3.3 India Bnp And Ntprobnp Market
        • 5.3.3.3.1 India Bnp And Ntprobnp Market by Location of Testing
        • 5.3.3.3.2 India Bnp And Ntprobnp Market by Application
      • 5.3.3.4 South Korea Bnp And Ntprobnp Market
        • 5.3.3.4.1 South Korea Bnp And Ntprobnp Market by Location of Testing
        • 5.3.3.4.2 South Korea Bnp And Ntprobnp Market by Application
      • 5.3.3.5 Singapore Bnp And Ntprobnp Market
        • 5.3.3.5.1 Singapore Bnp And Ntprobnp Market by Location of Testing
        • 5.3.3.5.2 Singapore Bnp And Ntprobnp Market by Application
      • 5.3.3.6 Malaysia Bnp And Ntprobnp Market
        • 5.3.3.6.1 Malaysia Bnp And Ntprobnp Market by Location of Testing
        • 5.3.3.6.2 Malaysia Bnp And Ntprobnp Market by Application
      • 5.3.3.7 Rest of Asia Pacific Bnp And Ntprobnp Market
        • 5.3.3.7.1 Rest of Asia Pacific Bnp And Ntprobnp Market by Location of Testing
        • 5.3.3.7.2 Rest of Asia Pacific Bnp And Ntprobnp Market by Application
  • 5.4 LAMEA Bnp And Ntprobnp Market
    • 5.4.1 LAMEA Bnp And Ntprobnp Market by Location of Testing
      • 5.4.1.1 LAMEA Point of Care Testing Market by Country
      • 5.4.1.2 LAMEA Laboratory Testing Market by Country
    • 5.4.2 LAMEA Bnp And Ntprobnp Market by Application
      • 5.4.2.1 LAMEA Myocardial Infarction Market by Country
      • 5.4.2.2 LAMEA Acute Coronary Syndrome (ACS) Market by Country
      • 5.4.2.3 LAMEA Congestive Heart Failure (CHF) Market by Country
      • 5.4.2.4 LAMEA Others Market by Country
    • 5.4.3 LAMEA Bnp And Ntprobnp Market by Country
      • 5.4.3.1 Brazil Bnp And Ntprobnp Market
        • 5.4.3.1.1 Brazil Bnp And Ntprobnp Market by Location of Testing
        • 5.4.3.1.2 Brazil Bnp And Ntprobnp Market by Application
      • 5.4.3.2 Argentina Bnp And Ntprobnp Market
        • 5.4.3.2.1 Argentina Bnp And Ntprobnp Market by Location of Testing
        • 5.4.3.2.2 Argentina Bnp And Ntprobnp Market by Application
      • 5.4.3.3 UAE Bnp And Ntprobnp Market
        • 5.4.3.3.1 UAE Bnp And Ntprobnp Market by Location of Testing
        • 5.4.3.3.2 UAE Bnp And Ntprobnp Market by Application
      • 5.4.3.4 Saudi Arabia Bnp And Ntprobnp Market
        • 5.4.3.4.1 Saudi Arabia Bnp And Ntprobnp Market by Location of Testing
        • 5.4.3.4.2 Saudi Arabia Bnp And Ntprobnp Market by Application
      • 5.4.3.5 South Africa Bnp And Ntprobnp Market
        • 5.4.3.5.1 South Africa Bnp And Ntprobnp Market by Location of Testing
        • 5.4.3.5.2 South Africa Bnp And Ntprobnp Market by Application
      • 5.4.3.6 Nigeria Bnp And Ntprobnp Market
        • 5.4.3.6.1 Nigeria Bnp And Ntprobnp Market by Location of Testing
        • 5.4.3.6.2 Nigeria Bnp And Ntprobnp Market by Application
      • 5.4.3.7 Rest of LAMEA Bnp And Ntprobnp Market
        • 5.4.3.7.1 Rest of LAMEA Bnp And Ntprobnp Market by Location of Testing
        • 5.4.3.7.2 Rest of LAMEA Bnp And Ntprobnp Market by Application

Chapter 6. Company Profiles

  • 6.1 Abbott Laboratories
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
    • 6.1.5 SWOT Analysis
  • 6.2 Siemens AG
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
    • 6.2.5 SWOT Analysis
  • 6.3 Danaher Corporation
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental and Regional Analysis
    • 6.3.4 Research & Development Expense
  • 6.4 Gentian Diagnostics ASA
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Regional Analysis
    • 6.4.4 Research & Development Expenses
  • 6.5 PerkinElmer, Inc.
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Segmental and Regional Analysis
    • 6.5.4 Research & Development Expense
  • 6.6 BioMerieux S.A.
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental and Regional Analysis
    • 6.6.4 Research & Development Expenses
  • 6.7 Quidel Corporation
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional Analysis
    • 6.7.4 Research & Development Expense
  • 6.8 Bio-Rad laboratories, Inc.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental and Regional Analysis
    • 6.8.4 Research & Development Expenses
  • 6.9 F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental and Regional Analysis
    • 6.9.4 Research & Development Expense
  • 6.10. Scripps Laboratories
    • 6.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 2 Global Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 3 Global Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 4 Global Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 5 Global Point of Care Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Point of Care Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Laboratory Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Laboratory Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 10 Global Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 11 Global Myocardial Infarction Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Myocardial Infarction Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Acute Coronary Syndrome (ACS) Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Acute Coronary Syndrome (ACS) Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Congestive Heart Failure (CHF) Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Congestive Heart Failure (CHF) Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Bnp And Ntprobnp Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Bnp And Ntprobnp Market by Region, 2022 - 2028, USD Million
  • TABLE 21 North America Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 22 North America Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 23 North America Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 24 North America Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 25 North America Point of Care Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 26 North America Point of Care Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 27 North America Laboratory Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Laboratory Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 30 North America Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 31 North America Myocardial Infarction Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Myocardial Infarction Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Bnp And Ntprobnp Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Bnp And Ntprobnp Market by Country, 2022 - 2028, USD Million
  • TABLE 41 US Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 42 US Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 43 US Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 44 US Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 45 US Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 46 US Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 47 Canada Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 48 Canada Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 49 Canada Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 50 Canada Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 51 Canada Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 52 Canada Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 53 Mexico Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 54 Mexico Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 55 Mexico Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 56 Mexico Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 57 Mexico Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 58 Mexico Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 59 Rest of North America Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 60 Rest of North America Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 61 Rest of North America Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 62 Rest of North America Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 63 Rest of North America Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 64 Rest of North America Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 65 Europe Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 66 Europe Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 67 Europe Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 68 Europe Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 69 Europe Point of Care Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 70 Europe Point of Care Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 71 Europe Laboratory Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 72 Europe Laboratory Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 73 Europe Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 74 Europe Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 75 Europe Myocardial Infarction Market by Country, 2018 - 2021, USD Million
  • TABLE 76 Europe Myocardial Infarction Market by Country, 2022 - 2028, USD Million
  • TABLE 77 Europe Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Europe Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
  • TABLE 80 Europe Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
  • TABLE 81 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 82 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 83 Europe Bnp And Ntprobnp Market by Country, 2018 - 2021, USD Million
  • TABLE 84 Europe Bnp And Ntprobnp Market by Country, 2022 - 2028, USD Million
  • TABLE 85 Germany Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 86 Germany Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 87 Germany Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 88 Germany Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 89 Germany Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 90 Germany Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 91 UK Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 92 UK Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 93 UK Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 94 UK Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 95 UK Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 96 UK Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 97 France Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 98 France Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 99 France Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 100 France Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 101 France Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 102 France Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 103 Russia Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 104 Russia Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 105 Russia Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 106 Russia Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 107 Russia Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 108 Russia Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 109 Spain Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 110 Spain Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 111 Spain Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 112 Spain Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 113 Spain Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 114 Spain Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 115 Italy Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 116 Italy Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 117 Italy Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 118 Italy Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 119 Italy Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 120 Italy Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 121 Rest of Europe Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 122 Rest of Europe Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 123 Rest of Europe Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 124 Rest of Europe Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 125 Rest of Europe Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 126 Rest of Europe Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 127 Asia Pacific Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 128 Asia Pacific Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 129 Asia Pacific Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 130 Asia Pacific Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 131 Asia Pacific Point of Care Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Asia Pacific Point of Care Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Asia Pacific Laboratory Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Asia Pacific Laboratory Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Asia Pacific Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 136 Asia Pacific Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 137 Asia Pacific Myocardial Infarction Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Asia Pacific Myocardial Infarction Market by Country, 2022 - 2028, USD Million
  • TABLE 139 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
  • TABLE 140 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
  • TABLE 141 Asia Pacific Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
  • TABLE 142 Asia Pacific Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
  • TABLE 143 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 144 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 145 Asia Pacific Bnp And Ntprobnp Market by Country, 2018 - 2021, USD Million
  • TABLE 146 Asia Pacific Bnp And Ntprobnp Market by Country, 2022 - 2028, USD Million
  • TABLE 147 China Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 148 China Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 149 China Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 150 China Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 151 China Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 152 China Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 153 Japan Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 154 Japan Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 155 Japan Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 156 Japan Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 157 Japan Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 158 Japan Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 159 India Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 160 India Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 161 India Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 162 India Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 163 India Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 164 India Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 165 South Korea Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 166 South Korea Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 167 South Korea Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 168 South Korea Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 169 South Korea Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 170 South Korea Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 171 Singapore Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 172 Singapore Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 173 Singapore Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 174 Singapore Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 175 Singapore Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 176 Singapore Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 177 Malaysia Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 178 Malaysia Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 179 Malaysia Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 180 Malaysia Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 181 Malaysia Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 182 Malaysia Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 183 Rest of Asia Pacific Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 184 Rest of Asia Pacific Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 185 Rest of Asia Pacific Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 186 Rest of Asia Pacific Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 187 Rest of Asia Pacific Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 188 Rest of Asia Pacific Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 189 LAMEA Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 190 LAMEA Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 191 LAMEA Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 192 LAMEA Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 193 LAMEA Point of Care Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 194 LAMEA Point of Care Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 195 LAMEA Laboratory Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 196 LAMEA Laboratory Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 197 LAMEA Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 198 LAMEA Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 199 LAMEA Myocardial Infarction Market by Country, 2018 - 2021, USD Million
  • TABLE 200 LAMEA Myocardial Infarction Market by Country, 2022 - 2028, USD Million
  • TABLE 201 LAMEA Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
  • TABLE 202 LAMEA Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
  • TABLE 203 LAMEA Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
  • TABLE 204 LAMEA Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
  • TABLE 205 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 206 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 207 LAMEA Bnp And Ntprobnp Market by Country, 2018 - 2021, USD Million
  • TABLE 208 LAMEA Bnp And Ntprobnp Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Brazil Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 210 Brazil Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 211 Brazil Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 212 Brazil Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 213 Brazil Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 214 Brazil Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 215 Argentina Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 216 Argentina Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 217 Argentina Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 218 Argentina Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 219 Argentina Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 220 Argentina Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 221 UAE Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 222 UAE Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 223 UAE Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 224 UAE Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 225 UAE Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 226 UAE Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 227 Saudi Arabia Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 228 Saudi Arabia Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 229 Saudi Arabia Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 230 Saudi Arabia Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 231 Saudi Arabia Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 232 Saudi Arabia Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 233 South Africa Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 234 South Africa Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 235 South Africa Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 236 South Africa Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 237 South Africa Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 238 South Africa Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 239 Nigeria Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 240 Nigeria Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 241 Nigeria Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 242 Nigeria Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 243 Nigeria Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 244 Nigeria Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 245 Rest of LAMEA Bnp And Ntprobnp Market, 2018 - 2021, USD Million
  • TABLE 246 Rest of LAMEA Bnp And Ntprobnp Market, 2022 - 2028, USD Million
  • TABLE 247 Rest of LAMEA Bnp And Ntprobnp Market by Location of Testing, 2018 - 2021, USD Million
  • TABLE 248 Rest of LAMEA Bnp And Ntprobnp Market by Location of Testing, 2022 - 2028, USD Million
  • TABLE 249 Rest of LAMEA Bnp And Ntprobnp Market by Application, 2018 - 2021, USD Million
  • TABLE 250 Rest of LAMEA Bnp And Ntprobnp Market by Application, 2022 - 2028, USD Million
  • TABLE 251 Key Information - Abbott Laboratories
  • TABLE 252 Key Information - Siemens AG
  • TABLE 253 Key Information - Danaher Corporation
  • TABLE 254 Key Information - Gentian Diagnostics ASA
  • TABLE 255 key Information - PerkinElmer, Inc.
  • TABLE 256 Key information - BioMerieux S.A.
  • TABLE 257 key information - Quidel Corporation
  • TABLE 258 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 259 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 260 Key Information - Scripps Laboratories

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Bnp And Ntprobnp Market Share by Location of Testing, 2021
  • FIG 3 Global Bnp And Ntprobnp Market Share by Location of Testing, 2028
  • FIG 4 Global Bnp And Ntprobnp Market by Location of Testing, 2018 - 2028, USD Million
  • FIG 5 Global Bnp And Ntprobnp Market Share by Application, 2021
  • FIG 6 Global Bnp And Ntprobnp Market Share by Application, 2028
  • FIG 7 Global Bnp And Ntprobnp Market by Application, 2018 - 2028, USD Million
  • FIG 8 Global Bnp And Ntprobnp Market Share by Region, 2021
  • FIG 9 Global Bnp And Ntprobnp Market Share by Region, 2028
  • FIG 10 Global Bnp And Ntprobnp Market by Region, 2018 - 2028, USD Million
  • FIG 11 Swot analysis: Abbott laboratories
  • FIG 12 Swot analysis: Siemens AG